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Abstract 
This paper discusses the diabetes “epidemic” (U.S. Centers for Disease Control and Prevention, [herein after 
CDC] https://www.cdc.gov/diabetes/library/features/diabetes-stat-report.html) in the United States. Specifically, 
the paper will discuss the racial disparity in diabetes disease prevalence and impacts between African Americans 
and Whites in the United States. The disproportionate prevalence, impacts, treatment, and care of diabetes 
between African Americans and Whites is particularly manifested in the diabetes related lower extremity 
amputations (LEA) undergone by African Americans compared to their White counterparts pertinent to causal, 
predisposing, and preventive factors. Through comparative analysis and using diabetic amputation rates, extant 
LEA encounter studies and data in the literature will be used to analyze and demonstrate “The Black American 
Amputation Epidemic” with implications for public policy and public health. Methodically, the paper conducted 
systematic review and meta-analysis of observational studies, government reports, secondary data, PubMed 
articles, Google Scholar Databases, published references. Consistent with existing empirical literature, the paper 
find and conclude that African Americans and other racial minorities suffer disproportionate preventable 
diabetes induced LEAs and deaths compared to Whites, further widening racial health care disparity problem. In 
addition, the paper adds to the body of knowledge and awareness of the increasing problem of diabetes on the 
African American population health germane to public policy intervention to reduce, if not totally eliminate the 
problem. Policy interventions including robust diabetes mitigation policy and leadership in the American health 
care system, more funding, research, education, better management, and preventive care for all patients at risk of 
amputation should be pursued, especially focusing on the historically underserved population. In this paper, the 
terms “Black (s),” “Black Americans,” “African Americans,” “racial minorities” and “people of color” are used 
interchangeably. 
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I. Introduction 
Globally, according to the World Health Organization [herein after WHO] the number of people with diabetes 
increased from 108 million in 1980 to 422 million in 2014, while the prevalence of diabetes among adults over 
18 years of age rose from 4.7% in 1980 to 8.5% in 2014  (WHO, 2020). In 2016, worldwide, an estimated 1.6 
million deaths were directly caused by diabetes, and between 2000 and 2016, there was a 5% increase in 
premature mortality from diabetes (WHO, 2020). Aside being the major cause of blindness, kidney failure, heart 
attacks, stroke and lower limb amputation (WHO, 2020), diabetes exacerbates major infectious diseases such as 
tuberculosis (TB), malaria and HIV/AIDS (WHO, 2012). People with diabetes are three times more likely to 
develop TB when infected and approximately 15% of TB globally is thought to be due to diabetes (WHO, 2012). 
The economic costs of diabetes is also enormous.  
In its “Global Report on Diabetes 2016” the WHO stated: “Diabetes and its complications bring about 
substantial economic loss to people with diabetes and their families, and to health systems and national 
economies through direct medical costs and loss of work and wages. While the major cost drivers are hospital 
and outpatient care, a contributing factor is the rise in cost for analog insulins2 which are increasingly prescribed 
despite little evidence that they provide significant advantages over cheaper human insulins” (p. 6). The United 
States is not immune to the global diabetes problem. 
There are 34.2 million people (10.5% of the population) in the United States with diabetes (CDC, National 
Diabetes Statistics Report 2020, p. 2), 88 million with pre-diabetes (34.5% of the population), and 1.5 million 
diagnosed new cases of diabetes every year (American Diabetes Association, 
https://www.diabetes.org/resources/statistics/statistics-about-diabetes). (Table 2). Diabetes is a source of 
considerable cost to the health care system (Rayman, et al. 2004, p. 1892). In the United States, diabetes and 
related complications are estimated to result in direct medical costs totaling $237 billion, and $90 billion of 
 
1 Ucheoma Nwagbara is an Adjunct Professor of Health Policy and Health Sociology at Southern University and A&M College, Baton 
Rouge, Louisiana, USA.  
2 These are insulins derived from human insulin by modifying its structure to change the pharmacokinetic profile. 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 




indirect costs due to reduced productivity from disability, absenteeism, and early mortality (American Diabetes 
Association, 2018). Between 2012 and 2017, excess medical costs per person associated with diabetes increased 
from $8,417 to $9,601, or 14% (CDC, National Diabetes Statistics Report 2020, p. 13). Also, diabetes is a 
leading cause of death and disability in the United States (Lord, Roberson, & Odoi, 2020). In fact, diabetes-
related mortality is considered the seventh (“and may be underreported” 
https://www.cdc.gov/diabetes/basics/quick-facts.html ) leading cause of death in the United States, after stroke 
and Alzheimer disease (Table 3, Xu et al. 2020; Kochanek et al., 2019). Furthermore, diabetes is the number one 
cause of kidney failure, lower-limb amputations, and adult blindness in the United States (CDC, 
https://www.cdc.gov/diabetes/basics/diabetes.html). The African American population and other racial 
minorities are hardest hit by the diabetes epidemic. 
Members of racial and ethnic minority groups in the United States, especially African Americans, suffer 
disproportionately from many chronic diseases, including diabetes (Signorello et al. 2007; Wong et al. 2002; 
Carter, Pugh, & Monterrosa, 1996; Cowie et al., 1989; Herman et al. 2007; Gaskin et al., 2014). At the same 
time, diabetes-related death is higher for minorities than for Whites, and it is not letting up (Carter, Pugh, & 
Monterrosa, 1996; CDC, 2007; Saydah et al., 2017). In addition, diabetes related amputations are done more 
frequently among African Americans than among Whites (9.0 per 1000 compared with 6.3 per 1000), and Pima 
Indians have 3.7 times more amputations than do Whites (Carter, Pugh, & Monterrosa, 1996). More recent 
studies re-affirm the foregoing with alarming pattern and prevalence. African Americans are more likely to have 
diabetes than Whites (Margolis, et al., 2011; Ko et al., 2014; Mitin et al., 2011; Gaskin et al., 2014; Link & 
McKinlay, 2013; Tan, et al., 2019), high prevalence of gestational diabetes (Sridhar et al., 2016; Hedderson et 
al., 2012; Nguyen et al., 2012), and obesity and diabetes are highly prevalent in women with Type I and II 
endometrial cancers, especially in African Americans (Ko, et al., 2014).  
How prevalent is diabetes among African Americans? African Americans have the highest prevalence rate 
of diabetes in the United States at 16.4% (Table 4). In addition, according to the American Diabetes Association, 
“Inequity systemically harms people of color…It contributes to worse outcomes and higher risk for diabetes and 
many other diseases” (https://www.diabetes.org/healthequitynow). The CDC offers a more vivid picture. 
According to the CDC (Diabetes - https://www.cdc.gov/media/presskits/aahd/diabetes.pdf):  
 African Americans are 1.7 times as likely to develop diabetes as whites 
 The prevalence of diabetes among blacks has quadrupled during the past 30 years 
 Among blacks age 20 and older, about 2.3 million have diabetes – 10.8 percent of that age group 
 Blacks with diabetes are more likely than non-Hispanic whites to experience greater disability from 
diabetes-related complications such as amputations, adult blindness, kidney failure, and increased risk 
of heart disease and stroke 
 Death rates for blacks with diabetes are 27 percent higher than for whites. 
Worse, African Americans have the highest diabetes mortality disparity in the United States (Rosenstock et 
al., 2014). Table 1 show that overall diabetes mortality rate in the United States (2005–2007, 3-year average) 
was 23.6/100,000 population (Rosenstock et al., 2014, p. 875). When categorized by race, the White diabetes 
mortality rate was 20.8 and the Black rate was 44.4, giving a rate ratio of 2.13 (95 % Confidence Interval: 2.11–
2.16). This study of African American/White racial disparity in diabetes mortality across the 50 most populous 
cities in the United States is very revealing. Table 1 presents in descending order city-level Black/White diabetes 
mortality rate ratios for 41 of the 50 most populous cities in the United States. All cities included in this analysis 
had Black mortality rates above the national average of 23.6. Of the 41 cities analyzed, 32 (78%) had Black 
mortality rates greater than the highest White mortality rate (Cleveland (34.5), and there were nearly 6,800 
annual excess Black diabetes deaths in the United States during the study period. Annual city-level excess Black 
deaths ranged from 442 in New York City to none in Detroit (-34), while the annual number of excess Black 
diabetes deaths in these cities accounted for 27% of all excess Black diabetes deaths in the United States. The 41 
cities included in this analysis represent 14% of the total United States population. 
The rest of the paper is organized as follows: Section II deals with diabetes basics (tabular description). 
Section III discusses determinants of diabetes prevalence. Section IV addresses diabetes amputations and the 
African American experience. Section V concludes the paper. 
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Table 1: Estimates (3-year) of Black/White Diabetes Mortality Disparity in the 50 Most Populous Cities in 
United States, 2005-2007 (N=41) 
 
Source: Adapted from Summer Rosenstock et al (2014), “Racial Disparities in Diabetes Mortality in the 
50 Most Populous US Cities.” Journal of Urban Health: Bulletin  
of the New York Academy of Medicine, 91(5), p.876.  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199450/pdf/11524_2013_Article_9861.pdf.  
 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 




Table 2: United States – Diabetes by the Numbers 
Item Description 
Diabetes    
Prevalence In 2018, 34.2 million Americans, or 10.5% of the population, had diabetes 
Diagnosed In 2018, 26.9 million Americans, including 26.8 million adults 
Undiagnosed In 2018, 7.3 million Americans, including 26.8 million adults 
Prevalence in seniors Americans age 65+ 26.8%, or 14.3 million seniors (diagnosed and 
undiagnosed) 
New cases 1.5 million Americans are diagnosed with diabetes every year 
Prediabetes   
18 years+  88 million people aged 18 years or older have prediabetes (34.5% of the 
adult U.S. population) 
65 years+ 24.2 million people aged 65 years or older have prediabetes 
Diabetes By Race/Ethnicity   
Non-Hispanic whites 7.5% adults 
Asian Americans 9.2% adults 
Hispanics 12.5% adults 
Non-Hispanic blacks 11.7% adults 
American Indians/Alaskan Natives 14.7% adults 
Cost of Diabetes   
Total cost $327 billion from diagnosed diabetes in the U.S. in 2017  
Direct medical cost $237 billion in the U.S. in 2017 
Reduced productivity $90 billion in the U.S. in 2017 
Number of Deaths   
Total (2017) 83,564 
Deaths/100,000 population 25.7 
Cause of death rank 7 
Sources: American Diabetes Association, “Statistics About Diabetes.” 
https://www.diabetes.org/resources/statistics/statistics-about-diabetes 
American Diabetes Association (2018), “Economic Costs of Diabetes in the U.S. in 2017.” 
https://care.diabetesjournals.org/content/early/2018/03/20/dci18-0007.full-text.pdf 
CDC - National Diabetes Statistics Report, 2020 
https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf 
CDC - A Snapshot: Diabetes in the United States 
https://www.cdc.gov/diabetes/library/socialmedia/infographics/diabetes.html 
CDC - National Center for Health Statistics - Diabetes 
https://www.cdc.gov/nchs/fastats/diabetes.htm  
CDC = United States Centers for Disease Control and Prevention 
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Table 3: United States: 15 Leading Causes of Death for the Total Population 2017 
Rank Cause of Death Number of Deaths Percent of Total Deaths 
 All Causes 2,813,503 100.0 
1 Diseases of heart 647,457 23.0 
2 Malignant neoplasms 599,108 21.3 
3 Accidents (unintentional injuries) 169,936 6.0 
4 Chronic lower respiratory disease 160,201 5.7 
5 Cerebrovascular diseases (e.g. stroke) 146,383 5.2 
6 Alzheimer disease 121,404 4.3 
7 Diabetes Mellitus 83,564 3.0 
8 Influenza and pneumonia 55,672 2.0 
9 Nephritis and nephrosis 50,633 1.8 
10 Suicide (intentional self-harm) 47,173 1.7 
11 Chronic liver disease and cirrhosis 41,743 1.5 
12 Septicemia 40,922 1.5 
13 Hypertension and renal disease 35,316 1.3 
14 Parkinson disease 31,963 1.1 
15 Pneumonitis due to solids and liquids 20,108 0.7 
  All other causes 561,920 20.0 
Source: Adapted from Kenneth D. Kochanek et al. (June 24, 2019). “Deaths:  
Final Data for 2017.” U.S. Department of Health and Human Services. Centers  
for Disease Control and Prevention. National Center for Health Statistics.  
National Vital Statistics Reports. 
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_09-508.pdf.  
 
Table 4: Estimated Prevalence of Diagnosed Diabetes, Undiagnosed Diabetes, 
and Total Diabetes Among Adults Aged 18 Years or Older, United States, 2013–2016 
 
      Source: Adapted from CDC – National Diabetes Statistics Report 2020, p. 2.  
      https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf.  
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II. Diabetes Basics 
Table 5: Diabetes, Symptoms, Risk Factors, Complications  
What is Diabetes Diabetes Symptoms Diabetes Risk Factors
Diabetes is a chronic disease that affects how 
the body turns food into energy and uses 
blood sugar (glucose). When blood sugar 
rises, it prompts the pancreas to release 
insulin. Insulin acts like a key to let the blood 
sugar into the body cells for use as 
energy.With diabetes, your body either 
doesn’t make enough insulin or can’t use it 
as well as it should.
Increased thirst, frequent urination, extreme 
hunger, unexplained weight loss, fatique 
(feel very tired), irritability, blurred vision, 
slow-healing sores, frequent infections.
Family history, age, overweight, inactivity, 
race or ethnicity, high blood pressure, 
environmental factors, geography.
Types of Diabetes Complications Diabetes Tests
There are Type 1, Type 2, and gestational 
diabetes. With Type 1 diabetes, the body 
immune system which normally fights 
harmful bacteria or viruses,  attacks and 
destroys the insulin-producing cells in the 
pancreas. This leaves your body with little or 
no insulin. Instead of being transported into 
your cells, sugar builds up in your 
bloodstream.With Type 2 diabetes your cells 
become resistant to the action of insulin, and 
your pancreas is unable to make enough 
insulin to overcome this resistance. Instead 
of moving into your cells where it's needed 
for energy, sugar builds up in your 
bloodstream. Gestational diabetes is 
pregnancy related. It occurs when the body 
cannot make enough insulin during 
pregnancy.
If you are diabetic you are more likely to 
have: cardiovascular diseases (e.g. heart 
attack, coronary artery disease with chest 
pain, stroke and narrowing of arteries); nerve 
damage (neuropathy - if left untreated could 
cause loss of feelings in limbs, for men it may 
lead to erectile dysfunction); kidney damage 
(nephropathy - can lead to kidney failure or 
permanent end-stage kidney disease, which 
may require dialysis or kidney transplant); 
eye damage (retinopathy - can cause 
cataracts and glycoma, and potentially lead 
to blindness); foot damage (nerve damage in 
the feet can cause infections to heal poorly, 
and if left unreated can lead to toe, foot, or 
leg amputation; hearing impairment (more 
common in people with diabetes); 
Alzeimers's disease (diabetes may increase 
the risk of dementia).
A1C Test (hemoglobin A1C or HBA1c test) 
measures your average blood sugar level 
over the past 2 or 3 months. An A1C below 
5.7% is normal, between 5.7 and 6.4% 
indicates you have prediabetes, and 6.5% or 
higher indicates you have diabetes.
 
Sources: CDC, Diabetes Basics https://www.cdc.gov/diabetes/basics/index.html  
CDC, Diabetes Tests https://www.cdc.gov/diabetes/basics/getting-tested.html  
Mayo Clinic, Diabetes 
https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444  
 
III. Determinants of Diabetes Prevalence 
While the reasons for racial disparities in diabetes prevalence are not clear, or “not well understood” (Golden et 
al. 2019), it has been suggested that behavioral, environmental, socioeconomic, physiological, and family history 
are risk factors (Signorello et al., 2007; Harris, 1990; Cowie et al., 1993; Harris et al., 1998; Carter, Pugh, & 
Monterrosa, 1996). These risk factors are collectively referred to as social determinants of health. For the sake of 
space and brevity, four risk factors of diabetes will be discussed beginning with socioeconomic factor, followed 
by obesity, environment, and discrimination.   
A. Socioeconomic Status  
Several studies have found that socioeconomic status is not only strongly correlated with diabetes, but also, 
diabetes is more prevalent in deprived  and depressed minority areas (Link & McKinlay, 2009;   Lord, Roberson, 
& Odoi, 2020; Connolly et al., 2000; Rabi et al., 2006; Jamil et al., 2008; Cunningham et al., 2008; Signorello et 
al., 2007). Wachtel (2005, p. 334) “family poverty accounts for differences in lower-extremity amputation rates 
of minorities.” One study (Link & McKinlay, 2009), for example, in the Boston Area Community Health 
(BACH) epidemiology based survey of 5,503 Boston (in the State of Massachusetts, United States) residents 
aged 30–79 (1,767 Black, 1,877 Hispanic, 1,859 White; 2,301 men and 3,202 women), on socioeconomic status 
(education and income) covariate, found that “Blacks and Hispanics have statistically significantly increased 
odds of having diabetes compared to Whites:” Blacks (12.8%), Hispanics (11.6%), and Whites (7.5%). Also, a 
2020 study in the State of Florida, United States, based on the state’s Behavioral Risk Factor Surveillance 
System respondents found that “disparities of pre-diabetes and diabetes exist in Florida” but most importantly 
“income level is a significant predictor of diabetes” (Lord, Roberson, & Odoi, 2013). Another study (Marley & 
Metzger, 2015) concluded that the “higher rates of obesity and type 2 diabetes in the American Indian young 
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adults than in the general U.S. population can be partially explained by neighborhood poverty” and economic 
“stress.” Piccolo et al. (2014) found “it is likely that non-genetic factors, specifically socioeconomic factors, 
account for much of the reported racial/ethnic disparities in type 2 diabetes mellitus (T2DM) incidence” and 
“childhood obesity overweight prevalence” ( Stamatakis & Cole, 2010).  
Butler (2017) investigation concluded “low family income and parental education…are common negative 
social determinants of health (SDOH) among families of youth with type 2 diabetes mellitus (T2DM).” Piccolo 
et al. (2016) study of “joint contributions of competing risk factors for T2DM” found that “socioeconomic 
factors had the greatest impact on explaining the excess prevalence of T2DM among racial/ethnic minorities.” In 
addition, in a study of the “50 most populous US cities,” Rosenstock et al (2014, p. 883) found that “nearly 75 % 
of the disparity in diabetes mortality rates between African Americans and Whites was explained by economic 
inequality and segregation.” The WHO summarized it neatly in its “Global Report on Diabetes 2016” (p.4): 
…“diabetes and its complications impact harshly on the finances of individuals and their families, and the 
economies of nations. People with diabetes who depend on life-saving insulin pay the ultimate price when access 
to affordable insulin is lacking.” 
B. Obesity 
Obesity can be defined as an excessive amount of fat that increases the risk of medical illness and premature 
death (Fock & Khoo, 2013). According to WHO, obesity has nearly tripled since 1975 (WHO, 2020). In 2016, 
more than 1.9 billion adults aged 18 years and older were overweight, with 13% being obese (WHO, 2020). In 
addition, in 2019, at least 40 million children under the age of 5 were overweight or obese (WHO, 2020). 
According to WHO, the main drivers of obesity include poor and misaligned diet, insufficient physical activity, 
sedentary lifestyle, changing mode of transportation, increasing urbanization (WHO, 2020). The United States is 
no exception. 
In the United States, it is forecast “a 33% increase in obesity prevalence and a 130% increase in severe 
obesity prevalence over the next 2 decades (Finkelstein et al., 2012). Also, in the United States (and globally) 
obesity has been found to be a major risk factor for diabetes (CDC, 2019; Alonso, Decora, & Bauer, 2019; 
Bhupathiraju & Hu, 2016; Chobot et al., 2018; OECD, 2019), especially among “African Americans compared 
with all other race and Hispanic origin groups” (Hales et al. 2020). The close relationship between obesity and 
diabetes has led to the connotation ‘diabesity,’ meaning that the majority of individuals with diabetes are 
overweight or obese (Leitner et al. 2017). Tajik et al. (2019) “being classified as overweight and obese increased 
the risk of T2DM in comparison with normal weight. Metabolically unhealthy (MUH) individuals are at higher 
risk of T2DM in all categories of body mass index (BMI) compared with metabolically healthy individuals.” In 
concordance, Janghorbani et al. (2017) “obesity is a risk factor for T2D with individuals who are metabolically 
healthy obese (MHO), metabolically unhealthy overweight (MUOW), and metabolically unhealthy obese 
(MUO) in excess risk of T2D.” The economic costs due to obesity can be burdensome (Loureiro & Nayga, 
2005).  
In the United States, for example, in 1990 the total economic cost of diabetes associated disease was put at 
estimated $68.8 billion, with direct cost of $45.8 billion and indirect cost of $23 billion (Wolf & Colditz, 1994). 
Five years later in 1995, the total cost attributable to obesity amounted to $99. 2 billion (5.7% of U.S. national 
health expenditure), out of which nearly $52 billion were direct medical costs, and approximately $4 billion in 
lost productivity, reflecting 39.2 million days of lost work (Wolf & Colditz, 2012). Currently in the United 
States, medical costs attributed to obesity were estimated $149.4 billion (Kim & Basu, 2016). In contrast, if 
obesity in the United States were to remain at 2010 levels, the combined savings in medical expenditures over 
the next 2 decades would be $549.5 billion (Finkelstein et al., 2012). Comparatively, the economic cost of 
obesity in the United States is similar to what is obtainable in “other industrialized countries which indicate that 
the cost of obesity is between 2% to 5% of the total cost of health care in industrialized nations” (Levy, Levy, & 
Basdevant, 1995). A recent report by the Organization for Economic Cooperation and Development (OECD), a 
body of industrialized economies, found that OECD spend estimated $311 billion annually to treat obesity 
induced diseases (OECD, 2019, p. 75).  Overall, obesity will cost the 52 OECD countries $425 billion per year, 
equating to average of 3.3% lower GDP, and 8% of total health spending (OECD, 2019, p.  75). Obesity is 
linked to environmental risk factor. 
C. Environmental Risk 
The influence of neighborhood and environmental factors on health is increasingly being recognized and studied 
in the recent years (Dendup et al, 2018; Diez Roux & Mair, 2010; Black & Macinko, 2008; Marshall, Brauer, & 
Frank, 2009; Hankey & Marshall, 2017; WHO, 2018). According to WHO, 24% of all global deaths are linked 
to environmental risk factors, roughly 13.7 million deaths annually (WHO, 2016). Also, more than one quarter of 
the 6.6 million under-five child deaths every year are associated with environment-related causes and conditions 
(WHO, 2016, p. 13). In addition, exposure to ambient air pollution is thought to increase the risk of premature 
birth, low birth weight and infant mortality (WHO, 2016, p. 44). And diabetes is no exception.  
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A recent Global Burden of Disease study covering 194 countries and territories found that PM2.53 air 
pollution is associated with “increased risk of diabetes…with the burden skewed more heavily towards low-
income and lower-to-middle-income countries” (Bowe et al., 2018, p. e301). The study estimate the attributable 
burden of disease (ABD) and disability-adjusted life-years (DALYs) of diabetes cases linked to environmental 
air pollution are highest in the ten most populous countries in the world (Table 6), China with the highest ABD 
of 600,000, followed by India with an ABD of 591,000, and the USA third, with an ABD of 150,000 (p. e305). 
Prior, the U.S. Environmental Protection Agency (EPA), found “people living with diabetes are considered at 
high risk for adverse health effects from exposure to harmful particles, or air pollution found both indoors and 
outdoors” (EPA, 2007). The poor air quality situation is worse in the communities and neighborhoods of 
racial/ethnic minorities in the United States (Ash & Boyce, 2018).  
Table 6: Attributable Burden of Diabetes Associated with Air Pollution 








 Global 3,002,900 40·6 
1 China 600,300 43·9 
2 India 590,500 44·9 
3 USA 149,500 46·3 
4 Pakistan 112,400 58·8 
5 Indonesia 104,800 40·7 
6 Bangladesh 69,800 43·1 
7 Brazil 49,800 23·8 
8 Russia 36,170 24·8 
9 Japan 34,900 27·7 
10 Nigeria 24,600 13·3 
Source: Benjamin Bowe et al. (2018). "The 2016 Global and  
National Burden of Diabetes Mellitus Attributable to PM2.5  
Air Pollution.” Lancet Planet Health, p. e306.  
https://www.thelancet.com/action/showPdf?pii=S2542-5196%2818%2930140-2.  
In the “United States,” argued Lambert (2019) “pollution, much like wealth, is not distributed equally,” or, 
as Brown et al. (2013) put it, “collective illness experience in the United States” is not the same for African 
Americans and Whites. Bullard (1993, p. 15) “Communities are not created equal. In the United States, for 
example, some communities are routinely poisoned while the government looks the other way. Environmental 
regulations have not uniformly benefitted all segments of society. People of color (African Americans, Latinos, 
Asians, Pacific Islanders, and Native Americans) are disproportionately harmed by industrial toxins on their jobs 
and in their neighborhoods.” The foregoing quotes go a long way to support the “charge that poor and minority 
communities are dumping grounds for environmental hazards” (Northridge & Shepard, 1997, p. 730). 
Concurring, Downey and Hawkins (2008, p. 759), “racial minorities are disproportionately burdened by 
environmental hazards.” Some scholars and analysts have called this phenomena “pollution inequity” (Tessum et 
al., 2019, p. 6001), “environmental racism” (Northridge & Shepard, 1997; Newkirk, 2018; Grossman, 1993, p. 
326; Bullard, 1993), “ecology of toxic inequality” (Sampson & Winter, 2016, p. 3), and “environmental 
injustice” (Brulle & Pellow, 2006), thereby reinforcing the health disparity gap between minorities and Whites. 
Many studies have explored this disparity (Gwynn & Thurston, 2001; Olden & White, 2005; Downey & 
Hawkins, 2011). More recently, according to the American Lung Association (2020a, p.44), “The burden of air 
pollution is not evenly shared. Poorer people and some racial and ethnic groups are among those who often face 
higher exposure to pollutants and who may experience greater responses to such pollution” and vulnerability to 
health problems.  
The most recent EPA review of the research on the health effects of particle pollution (American Lung 
Association, 2020b) concluded that “there is strong evidence demonstrating that black and Hispanic populations, 
in particular, have higher risk exposures than non-Hispanic white populations’’ (U.S. EPA, 2019, section 12.5.4) 
and that ‘‘there is consistent evidence across multiple studies demonstrating an increase in risk for nonwhite 
populations” (U.S. EPA, 2019, pp. 12-38). [See also Federal Register, vol. 85, no. 84, April 30, 2020, p. 24114]. 
Also, due to decades of residential segregation and redlining, African Americans tend to live where there is 
greater exposure to air pollution (Nardone, et al., 2020) and by implication are more susceptible to health risks 
 
3 “PM2.5 is the most widely studied air pollutant—is associated with increased risk of cardiovascular disease, pulmonary 
disease, kidney disease, and other non-communicable diseases and contributed to about 4·2 million premature deaths in 
2015” (Bowie, et al., 2018). 
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including diabetes. A 2019 study by the American based Union of Concerned Scientists, a nonprofit science 
advocacy, found “inequitable exposure to air pollution from vehicles in American Northeast and Mid-Atlantic 
regions, with communities of color breathing 66 percent more air pollution than White residents.” Another 2016 
study found that long-term exposure to airborne pollution is associated with racial segregation, with more highly 
segregated areas suffering higher levels of exposure (Bravo et al., 2016). As also, racial segregation is suspected 
in the prevalence of lead poisoning in the African American neighborhoods and has contributed to the legacy of 
Black disadvantage in the United States (Sampson & Winter, 2016). 
In Louisiana, for example, the region between Baton Rouge and New Orleans has been infamously called 
the “Cancer Alley”4 (Pezzullo, 2003; Berry 2003; Taylor 2014) because this area, particularly “predominantly 
Black and poor communities” (Baurick, Younes, & Meiners, 2019) “host a disproportionate number of 
hazardous and noxious facilities” (Taylor, 2014, p. 2) including “about 135 petrochemical plants” (Taylor, 2014, 
p. 20), that tend to release “air toxins and pollutants known or suspected to cause cancer or other serious health 
problems” (Louisiana Department of Environmental Quality, Air Toxics Monitoring, n.d.). In fact, it has been 
found that “numerous cancer cases occur in the Cancer Alley”5 (Taylor, 2014, p. 20), as people living in the 
Cancer Alley are “more than 50 times as likely to get cancer than the average American” (Pasley, 2020), and 
“while air quality has improved for decades across the U.S., but Louisiana is backsliding…a crush of new 
industrial plants will increase concentrations of cancer-causing chemicals in predominantly black and poor 
communities” (Baurick, Younes, & Meiners, 2019).The federal cancer picture mimic Louisiana’s. 
A CDC and National Cancer Institute study of cancer death rates from 2013 to 2017 indicates that African 
Americans are more likely to die from cancer than any other racial group in the United States (CDC & National 
Cancer Institute, 2020). In the 2013-2017 study period, the death rate from all cancers was 181.7 per 100,000 for 
African Americans (compared to 158.3 per 100,000 nationally), 159.0 per 100,000 for Whites, 98.9 per 100,000 
for Asian and Pacific Islanders, 106.2 per 100,000 for Native Americans, and 112.3 per 100,000 for Hispanic 
(CDC & National Cancer Institute, 2020). Cancer is the second leading cause of death in the United States, after 
heart disease. One of every four deaths in the United States is due to cancer (CDC & National Cancer Institute, 
2020). In 2017 (latest incidence data available), in the United States, 1,701,315 new cases of cancer were 
reported, and 599,099 people died of cancer. For every 100,000 people, 438 new cancer cases were reported and 
153 people died of cancer (CDC & National Cancer Institute, 2020). Accordingly, the long association of 
environmental inequity with minority communities in the United States continue to reinforce health disparity, not 
the least diabetes occurrence and impact. Environmental inequity is linked to racial discrimination with 
implications for diabetes risk factors. 
D. Discrimination 
Nwagbara (2020) found that racial discrimination is partly to blame for African Americans health disparity 
problem in the United States. Another recent report found that close to “25% of African Americans avoid 
medical care even when in need, for fear of discrimination” (Harvard T.H. Chan School of Public Health, Robert 
Wood Johnson Foundation, and National Public Radio, 2017, p. 1). The literature further reveal that due to racial 
discrimination African Americans tend to receive low quality of care for basic hospital services (Ayanian, 1999; 
Noonan, Velasco-Mondragon, & Wagner, 2016; Scott & Wilson, 2011; Gerend & Pai, 2008; Hostetter & Klein, 
2018). Pinderhughes (1996, p. 231) “most common victims of environmental hazards and pollution are 
minorities and the poor. Disproportionate exposure to environmental hazards is part of the complex cycle of 
discrimination and deprivation faced by minorities in the United States” including health inequity. The impact of 
discrimination/racism on diabetes outcomes is no exception.  
Robert Anderson (1998, p. 689) observed “in the United States racism and diabetes are in the heart of 
darkness.” Tull and Chambers (2001) echoed similar sentiments, “internalized racism is associated with glucose 
intolerance among Black Americans…may also contribute to the unexplained excess of type 2 diabetes in that 
group.” Wagner et al. (2011, p. 224) found that “African American women believed that racism affects their 
diabetes self-management and control…with exposure to novel racial stressors.” Bacon et al. (2017) “Black 
Women’s Health Study” of 59,000 African American women spanning 16 years period found “exposure to 
‘every day racism’ (interpersonal racism in daily life) and ‘lifetime racism’ (treated unfairly due to race with 
respect to police, housing or work) increased risk of type 2 diabetes.” 
Moody-Ayers et al. (2005) study of “perceived societal racism in African Americans aged 50 and older with 
 
4  Cancer Alley parishes (counties) includes: Ascension, Assumption, East Baton Rouge, Iberville, Jefferson, Orleans, 
Plaquemines, St. Charles, St. James, St. John the Baptist, West Baton Rouge (Taylor, 2014, p. 20). 
5 According to the CDC, in 2017 (latest data), Louisiana had the fifth-highest cancer death rate in the country, for every 
100,000 people in Louisiana, 175 died of cancer, behind Kentucky (186), Mississippi (183), West Virginia (179), 
Oklahoma (177).  
Source: CDC and National Cancer Institute (June 2020). “Cancer Burden: All Types of Cancer, 2017.” United States Cancer 
Statistics: Data Visualizations.  
https://gis.cdc.gov/Cancer/USCS/DataViz.html.   
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type 2 diabetes mellitus” found that “patients' day‐to‐day experiences of societal racism can influence the patient 
trust in the medical system and their adherence to medical advice or engagement in self‐management of their 
chronic conditions.” Auslander et al. (1997) investigation concluded, “mothers of children with diabetes who 
reported greater perceptions of racism were significantly less satisfied with their children's medical care than 
those from less stressful environments.” Nowhere is the health complications6 of diabetes more pronounced than 
in the disparity in limb amputation risks between ethnic minorities and Whites. To put it vividly, Presser (2020) 
“ they [African Americans] are disproportionately diabetic…put at risk by an array of factors, from unequal 
health care access to racist biases to cuts in public health funding. These elements have long driven disparities, 
particularly across the South. One of the clearest ways to see them is by tracking who suffers diabetic 
amputations, which are, by one measure, the most preventable surgery in the country” [America]. 
 
IV. Diabetic Amputations: The African American Experience 
According to WHO, the global cases of diabetes rose more than 290% in 2014 from 1980, representing 422 
million patients (WHO, 2020). This has led to increasing number of individuals with diabetic foot disease, up to 
75% of lower extremity amputations (LEAs) being performed in these patients (Narres, 2017, p. 2). The United 
States is no exception. 
Back in 2001 Wrobel, Mayfield, and Reiber found that in the United States “patients with diabetes were 10 
times more likely to undergo major amputation” (p. 861). Nearly twenty years later in 2018, a major report in the 
Diabetes Care, the official journal of the American Diabetes Association reached a similar conclusion, indicated 
that diabetic related “lower-limb amputations may be rising in the United States after decades of decline” 
(Caffrey, 2018). According to the study which covered the years between 2009 and 2015, the rate of amputations 
in the United States grew 50% during the period under review (Geiss, et al., 2018). In the United States, 
diabetics undergo about 120,000 amputations each year (Geiss, 2018, p. 53), often in low-income and 
underinsured neighborhoods (Presser, 2020). The problem is worse in the African American population.  
Table 7 shows the outcomes of patients admitted to the hospital from 2003-2015 7  for diabetic foot 
infections (DFIs) across various racial/ethnic groups including Whites, African Americans, Hispanics, and 
Native Americans (Tan, et al., 2019). Applying multivariable logistic models, the researchers studied the 
association between racial and ethnic groups and outcomes, including major (lower extremity amputation above 
the ankle) and minor (amputation below the ankle) amputations, endovascular intervention, and open surgery 
(Tan, et al., 2019). Major amputations were highest for African Americans (7.6%), followed by Native 
Americans (7.1%) and Hispanics (6.9%), than it is for Whites (5.4%). Similarly, the number of minor 
amputations were highest for African Americans (31.6%), followed by Hispanics (31.5%), than Whites (29.3%), 
and Native Americans (27.8%).   
Table 7: Outcomes of Patients with Diabetic Foot Infections, 2003-2015 
 
Source: Adapted from Tze-Woei Tan et al (2019). “Disparities in Outcomes of Patients Admitted with Diabetic 
Foot Infections.” PLoS ONE 14(2), e0211481. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361439/pdf/pone.0211481.pdf.  
 
6 Diabetic foot ulcers (DFU) and diabetic foot infections (DFI) are the leading causes of amputations (Lefebvre & Lavery, 
2011). African Americans (AAs), Hispanics, and Native Americans (NAs) have a higher prevalence of diabetes than 
Whites (Spanakis & Golden, 2013; CDC, n.d.; Cheng, et al., 2019). Consequently, the incidence of DFUs and 
amputations are disproportionately higher in AAs, Hispanics, and NAs (Lavery et al. 1996; Margolis, et al., 2011, Data 
Points #1 and #2; Tan, et al., 2019). 
7 The study utilized National Inpatient Sample (NIS). The NIS is part of the Healthcare Cost and Utilization Project (HCUP), 
is the largest publicly available all-payer health care database and collects data for more than 7 million hospital stays 
every year (Tan, et al., 2019).  
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Other studies have also reached similar conclusions. According to a recent Dartmouth study, Black patients’ 
amputation rate is nearly three times higher than the rate among others (Goodney, et al., 2014, p. 12). “Racial 
and ethnic minorities” wrote Fakorede (2018) not only “have a higher prevalence and greater burden of diabetes 
compared with Whites,” but also, “African Americans are 4 times more likely to experience diabetes-related 
amputation than Whites.” “Blacks and Hispanics with…diabetes experience a greater incidence and odds of 
amputation when compared with Whites” (Lefebvre & Lavery, 2011; Margolis, et al, 2011; Goldberg, et al. 
2012; Fakorede, et al., 2019; Girijala & Bush, 2018). Earlier, Feinglass et al. (2008) census data analysis of 
racial disparities in lower extremity amputation rates in Northern Illinois, 1987-2004 (18 years) found that 
“despite progress in reducing the overall major amputation rate in northern Illinois, racial disparities have 
remained remarkably constant.” The “predominantly African American area of the South and West sides of 
Chicago, with less than 15% of the area population, accounted for 27% of all amputation discharges.”  
Rucker-Whitaker, Feinglass, and Pearce (2003) analysis of “population-based hospital data indicate that 
African American patients undergo major lower extremity (LE) amputation 2 to 3 times more frequently than 
white patients.” The disparity is because “African American patients undergo repeat major amputation at a 
significantly higher rate than Whites.” Goldberg et al. (2012) exploration of Medicare diabetic patients 23,976 
amputations between 1999 and 2006, found that “high-risk patients represent a minority of Medicare diabetic 
patients but account for 50% of all amputations, and this effect is magnified in African Americans.” Lavery et al. 
(1997) found “African Americans diabetes higher prevalence or severity of risk factors may explain the excess 
mortality observed in African-Americans following lower extremity amputations.” In all, Presser (2020) has 
called it “The Black American Amputation Epidemic.”  
Mississippi Delta - “Black American Amputation Epidemic” Epicenter 
Geographic variation cluster analysis in the rate of diabetic prevalence, amputation, and mortality is in order. 
The Mississippi Delta region 8  is a case in point. The region has the highest concentration of diabetic 
amputations, prevalence, and mortality in the United States (Figures 1, 2, and 3). Mississippi has been called the 
“amputation capital of the United States” and it is considered the epicenter of the diabetic “Black American 
Amputation Epidemic” (Presser, 2020). Also, Mississippi has a large African American population,9 it has one of 
the highest rates of diabetes (rank number 3, Table 8), and the highest poverty rate at 19.1% (same as Louisiana) 
in the United States.10 Consequently, Mississippi11 can be generalized as representative of the diabetes induced 
“Black American Amputation Epidemic” with its “dire implications for disability and mortality” (Wrobel, 
Mayfield, & Reiber, 2001, p. 862). The “Black American Amputation Epidemic” toll is so heavy in the 
Mississippi Delta that one Dr. Foluso Fakorede, “a crusading cardiologist” and the “only cardiologist in Bolivar 
County, Mississippi” (Presser, 2020) has envisioned building a lab called “Amputation Prevention Institute” 
(Presser, 2020) in the Delta. 
 
8  The Mississippi Delta region runs across eight states: Alabama, Arkansas, Illinois, Kentucky, Louisiana, Mississippi, 
Missouri, and Tennessee. Source: Delta Regional Authority (2015, February). “Today’s Delta – A Research Tool for the 
Region.” Second Edition.  
https://dra.gov/images/uploads/content_files/Todays_Delta_FINAL_print-w-borders.pdf.  
9 African American population is 1,103,101 or 37% of the total 2,967,297 Mississippi population estimate in 2018. 
Mississippi’s 37% African American population is nearly double the average of 22% African American population in the 
South. Source: U.S. Census Bureau. American Fact Finder.https://www2.census.gov/programs-
surveys/popest/tables/2010-2018/state/asrh/PEPSR6H.pdf 
10Jessica Semega et al. (2020, September 15). “Income and Poverty in the United States: 2019.” U.S. Census Bureau. 
https://www.census.gov/library/publications/2020/demo/p60-270.html.  
11  In 2016, Mississippi ranked first in the nation for overall diabetes prevalence, with an estimated 308,295 adult 
Mississippians living with diabetes (over 13.6% of the adult population). Mississippi Department of Health. 
https://msdh.ms.gov/msdhsite/_static/43,0,296.html.  
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Figure 1: Average Annual Amputations, 2007-9 
 
Adapted from Lizzie Presser (May 19, 2020). “The Black American Amputation Epidemic.”  
PROPUBLICA. 
https://features.propublica.org/diabetes-amputations/black-american-amputation-epidemic/.  
Lower extremity amputation (LEA) in patients with diabetes results in high mortality, reduced quality of 
life, and increased medical costs (Narres, et al., 2017, p. 1). Diabetic persons have a 15 times higher risk of LEA 
than nondiabetic individuals (Most & Sinnock, 1983; Bild et al., 1989) and elevated risk of foot ulcer as a result 
(Paisey, et al. 2018). African Americans and other historically underserved populations are less likely to get 
lower extremity amputation alternative attention such as, “prior arterial intervention and peripheral vascular 
intervention (PVI) than Whites” (Fakorede, et al. 2019).  In the same breath, African Americans are more likely 
to undergo primary amputation than revascularization to improve arterial blood flow than Whites (Tan, et al., 
2019). Furthermore, it is widely believed that African-American patients experience worst quality of life after 
PVI, than their White counterparts (Fakorede, et al., 2019; Zaitoun, et al., 2017), leading to more health 
comorbidities. Also, it has been shown that “African American are less likely to be evaluated with an angiogram 
than are White patients” (Henry, et al., 2011), leading to the “conclusion that physicians should not be dissuaded 
from treating African-American patients with PVI when appropriate” (Fakorede, et al., 2019).  
 
Figure 2: County-level Prevalence of Diagnosed Diabetes among Adults Aged 20 Years or Older, United 
States, 2004, 2008, and 2016 
 
Adapted from CDC, National Diabetes Statistics Report 2020, p. 5 
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Figure 3: United States - Diabetes Mortality by State 
 
1The number of deaths per 100,000 population 




Table 8: United States - Diabetes Death Rate* by State 2018 
Rank State  Rate Rank State Rate 
1 West Virginia 36.2 25 Wyoming 21.4 
2 Arkansas 32.3 27 Texas 21.1 
3 Mississippi 30.6 28 Missouri 20.8 
4 Oklahoma 29.0 29 Washington 20.4 
5 Kentucky 27.9 30 Illinois 20.3 
6 Louisiana 26.9 31 Pennsylvania 20.2 
7 New Mexico 26.1 31 Wisconsin 20.2 
8 Iowa 26.0 33 Florida 19.8 
8 Nebraska 26.0 34 Maryland 19.6 
10 Ohio 25.4 35 Alabama 19.4 
11 South Carolina 24.8 36 Nevada 19.2 
12 Tennessee 24.5 37 Montana 19.1 
13 North Dakota 24.1 38 Delaware 18.8 
14 North Carolina 23.9 38 Minnesota 18.8 
15 Utah 23.5 40 Indiana 18.6 
16 Maine 23.4 41 New York 18.2 
17 South Dakota 23.3 41 Vermont 18.2 
18 Oregon 22.9 43 Alaska 17.7 
19 Virginia 22.9 44 New Hampshire 17.3 
20 Kansas 22.6 45 Rhode Island 17.2 
21 Arizona 22.4 46 New Jersey 16.6 
22 Georgia 22.1 47 Colorado 16.1 
23 Idaho 21.9 47 Hawaii 16.1 
23 Michigan 21.9 49 Massachusetts 15.8 
25 California 21.4 50 Connecticut 14.6 
   *Per 100,000 total population 
   Source: U.S. Centers for Disease Control and Prevention (CDC),  
“Diabetes Mortality by State” and author’s calculation 
   https://www.cdc.gov/nchs/pressroom/sosmap/diabetes_mortality/diabetes.htm.  
 
V. Conclusion and Policy Recommendations 
This paper examined the diabetes “epidemic” in the United States and its devastating impact on African 
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Americans health, compared to Whites. The paper find that diabetes not only has disproportionate impact on the 
health of African Americans, especially lower limb amputations, but also, it has widened the gap in health 
disparity between African Americans and Whites. As Girijala and Bush (2018) put it, “the current body of 
literature and data analyses show a clear association between race, coexisting diseases, and the risk of a negative 
limb outcome.” In addition, there is a strong correlation between African American high diabetes prevalence and 
risk factors of poverty, obesity, environment, and discrimination. The findings are consistent with the body of 
research in the empirical literature as has been quoted profusely in the paper. Furthermore, the findings will be 
important to health care policymakers, administrators, providers, educators, analysts, and students as well as 
advocates for underserved populations towards policy solutions for health disparity. 
Diabetes should be treated as a major public health problem for African Americans and other peoples of 
color. To address race disparities in diabetes prevalence and care, policymakers should address diabetes enabling 
factors including poverty, obesity, nutrition imbalance, environmental toxins, racial discrimination, and poor 
housing.  The following measures could be taken to control and the reverse the trend of diabetes exposure in the 
African American population:  
 Better understanding of the complex roles that economic inequality, discrimination, environment, housing 
segregation, obesity play in the disproportionate burden of diabetes in the African American population 
 Know that diabetes is a public health crisis just as “Racism is a public health crisis” (Michelle Williams, 
T.H. Chan School of Public Health, Harvard University). https://www.hsph.harvard.edu/news/racism-is-a-
public-health-crisis/.  
 Government policies, laws, and hospital practices should encourage equitable care for at risk-patients and 
aim to end racial disparity in amputations.12 
 Allocate more funding for education, research, prevention, and better management of diabetes. 
 Black physician leadership will be necessary if African American health disparity is to be resolved (Byrd & 
Clayton, 1992, p. 189; deShazo, Smith, & Skipworth, 2014, Part 1and 2; deShazo and Parker, 2018), and 
diabetes is no exception. As Dr. David Satcher, African American, former Surgeon General of the United 
and the director of the Centers for Disease Control and Prevention, astutely suggested: “this…leaders must 
be prepared to effect critical public policy decisions, including improvements in access to quality care, and 
health promotion and disease prevention, with the goal of eliminating disparities in health and achieving 
health equity” (Satcher, 2020, p. 11). 
 Continue to monitor and reduce disparities - the Agency for Healthcare Research and Quality (AHRQ) 
publishes an annual national report highlighting disparities in health care quality by race/ethnicity, age, and 
sex; the Office of Minority Health is tasked with developing policies and programs to eliminate disparities 
among racial and ethnic minority groups; the Health Resources and Services Administration (HRSA) is 
tasked with providing grants to states, local governments, and community-based organizations for care and 
treatments for low-income, uninsured, or other vulnerable populations; the Indian Health Service serves 
American Indians and Alaska Natives who belong to more than 500 federally recognized tribes in 37 states, 
and the service is fully funded through the federal government (Tikkanen, et al., 2020). 
 Boost primary care – according to experts, “primary care is the means by which the two main goals of a 
health services system, optimization and equity of health status, are approached.” Primary care provides the 
entry into the system for all new needs and problems, provides person-focused (not disease-oriented) care, 
and coordinates or integrates care, regardless of location and provider (Johns Hopkins University, 
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12  In October 2020, for example, Congressman Donald M. Payne Jr., a Democrat from New Jersey, introduced a 
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Reduction and Compassion Act of 2020.”  
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